General Information
edit

Website	kuros.ch
Category	BioTech
Phone	41-(0)44-200-56-00
Email	info@kuros.ch
Employees

Offices
edit

Zurich, CHE

Technoparkstrasse 1
Zurich, CH-8005, CHE

Funding
edit

TOTAL	$9.78M
FUNDING TOTAL	$9.78M
Series B, 1/05 NeoMed CDC Innovation Genevest Consulting Group VINCI CAPITAL DEFI Gestion VI Partners	€4M
Venture Round, 10/05 NeoMed CDC Enterprises Genevest Consulting Group VINCI CAPITAL DEFI Gestion VI Partners	€3.6M

Tags
edit

Kuros Biosurgery
edit

Kuros Biosurgery is a biotechnology company dedicated to developing biomaterials and bioactive biomaterial combination products for indications in trauma, wound and spine. Kuros products are based on two different matrix technologies that allow the attachment of biologics or drugs and that can be applied locally.

Recent Milestones
edit

Kuros Biosurgery received $4.34M (€3.6M) in Venture Round funding. (10/1/05)

Posted 8/31/10 at 12:41am via kuros.ch
Kuros Biosurgery received $5.45M (€4M) in Series B funding. (1/1/05)

Posted 8/30/10 at 2:46am via kuros.ch